Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Managed Healthcare Industry Analysis

UpdatedJun 16, 2026
DataAggregated Company Financials
Companies11
  • 7D0.7%
  • 3M47.1%
  • 1Y26.4%
  • YTDn/a

In the last week, the Managed Healthcare industry is flat overall, with Elevance Health standing out by going down 3.9%. The past year has been better, since the industry has gained 26% in that time. Earnings are forecast to grow by 20% annually.

Industry Valuation and Performance

Has the U.S. Managed Healthcare Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 17 Jun 2026US$563.0bUS$1.0tUS$12.4b31.3x45.3x0.6x
Fri, 15 May 2026US$541.2bUS$1.0tUS$12.4b31.1x43.6x0.5x
Sun, 12 Apr 2026US$406.8bUS$1.0tUS$12.9b19.4x31.5x0.4x
Tue, 10 Mar 2026US$387.4bUS$1.0tUS$12.9b18x30.1x0.4x
Thu, 05 Feb 2026US$400.8bUS$991.6bUS$14.8b17.9x27.1x0.4x
Sat, 03 Jan 2026US$452.1bUS$974.8bUS$20.2b17.3x22.4x0.5x
Mon, 01 Dec 2025US$446.9bUS$974.8bUS$20.1b17x22.2x0.5x
Wed, 29 Oct 2025US$482.8bUS$950.7bUS$31.4b14.6x15.4x0.5x
Fri, 26 Sep 2025US$466.1bUS$944.0bUS$31.5b14x14.8x0.5x
Sun, 24 Aug 2025US$424.0bUS$943.9bUS$31.5b13.2x13.5x0.4x
Tue, 22 Jul 2025US$383.7bUS$920.1bUS$33.9b11.6x11.3x0.4x
Thu, 19 Jun 2025US$452.1bUS$913.9bUS$34.4b14x13.1x0.5x
Sat, 17 May 2025US$426.4bUS$913.9bUS$34.4b15.2x12.4x0.5x
Mon, 14 Apr 2025US$748.8bUS$887.6bUS$26.1b23.1x28.7x0.8x
Wed, 12 Mar 2025US$625.2bUS$887.6bUS$26.1b20.5x24x0.7x
Fri, 07 Feb 2025US$689.9bUS$885.4bUS$26.1b20x26.4x0.8x
Sun, 05 Jan 2025US$651.6bUS$873.5bUS$26.2b19x24.9x0.7x
Tue, 03 Dec 2024US$753.3bUS$873.5bUS$26.2b19.1x28.7x0.9x
Thu, 31 Oct 2024US$707.7bUS$870.5bUS$26.6b17.5x26.6x0.8x
Sat, 28 Sep 2024US$759.7bUS$855.9bUS$26.3b20.7x28.9x0.9x
Mon, 26 Aug 2024US$782.5bUS$855.8bUS$26.3b21.9x29.8x0.9x
Wed, 24 Jul 2024US$741.5bUS$850.1bUS$26.4b20.4x28.1x0.9x
Fri, 21 Jun 2024US$672.6bUS$844.2bUS$27.2b20.8x24.7x0.8x
Sun, 19 May 2024US$726.5bUS$844.1bUS$27.2b21x26.7x0.9x
Tue, 16 Apr 2024US$629.6bUS$829.6bUS$34.4b18.9x18.3x0.8x
Thu, 14 Mar 2024US$686.8bUS$829.5bUS$34.4b20x20x0.8x
Sat, 10 Feb 2024US$720.0bUS$832.8bUS$33.3b20.3x21.6x0.9x
Mon, 08 Jan 2024US$741.0bUS$811.8bUS$32.8b20.9x22.6x0.9x
Wed, 06 Dec 2023US$753.3bUS$809.0bUS$33.9b21.7x22.2x0.9x
Fri, 03 Nov 2023US$724.7bUS$809.2bUS$33.8b21.1x21.4x0.9x
Sun, 01 Oct 2023US$697.7bUS$789.4bUS$34.2b21.5x20.4x0.9x
Tue, 29 Aug 2023US$683.2bUS$789.4bUS$34.2b20.3x20x0.9x
Thu, 27 Jul 2023US$706.8bUS$784.9bUS$32.6b22.4x21.7x0.9x
Sat, 24 Jun 2023US$669.9bUS$767.3bUS$31.9b21.5x21x0.9x
Price to Earnings Ratio

21x


Total Market Cap: US$669.9bTotal Earnings: US$31.9bTotal Revenue: US$767.3bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Managed Healthcare Industry Price to Earnings3Y Average 23.5x202420252026
Current Industry PE
  • Investors are optimistic on the American Managed Healthcare industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 45.3x which is higher than its 3-year average PE of 23.4x.
  • The industry is trading close to its 3-year average PS ratio of 0.70x.
Past Earnings Growth
  • The earnings for companies in the Managed Healthcare industry have declined 27% per year over the last three years.
  • Meanwhile revenues for these companies have grown 9.9% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does U.S. Managed Healthcare compare with similar industries?

US Market2.20%
Healthcare0.64%
Healthcare Services1.97%
Managed Healthcare0.72%
Healthcare Services3.71%
Healthcare Facilities3.37%
Healthcare Distributors2.43%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
UNH UnitedHealth GroupUS$411.041.1%
+US$4.1b		33.6%PE31x
ALHC Alignment HealthcareUS$19.7828.9%
+US$915.8m		36.4%PE206.5x
HUM HumanaUS$369.491.7%
+US$757.6m		53.0%PE39.3x
CLOV Clover Health InvestmentsUS$4.8122.7%
+US$468.7m		64.7%PS1.1x
MOH Molina HealthcareUS$201.871.7%
+US$180.2m		-30.4%PE55.9x

Latest News

HUM
US$369.49
Humana
7D
1.7%
1Y
53.0%
Analysis Article • 15h

Humana (HUM) Stock Could Be 78.6% Overvalued After Its Recent Rally

Humana (HUM) has drawn fresh attention after recent trading, with the stock showing a mix of short term gains and longer term declines that raises questions about how investors currently view its valuation. See our latest analysis for Humana. Recent trading has pushed Humana’s share price to $380.26, with a 30 day share price return of 24.63% and a 1 year total shareholder return of 64.10%. However, 3 and 5 year total shareholder returns remain in decline, suggesting momentum has recently...
ELV
US$397.80
Elevance Health
7D
-6.3%
1Y
6.0%
Narrative Update • Jun 16

ELV: CMS Sanction Resolution And Stable Policy Backdrop Will Support Margin Recovery

Elevance Health's analyst price target has been revised upward by $4.63 to $498.00. Analysts point to a more stable managed care policy backdrop, muted medical cost trends, and ongoing margin recovery efforts as key supports for the higher fair value and slightly stronger revenue growth, profit margin, and forward P/E assumptions.
UNH
US$407.65
UnitedHealth Group
7D
-1.3%
1Y
32.0%
Narrative Update • Jun 15

UNH: Medicare Advantage Recovery And Calmer Policy Backdrop Will Support Earnings Resilience

Analysts have lifted the UnitedHealth Group fair value estimate to $492 from $440, citing updated healthcare services models, expectations for a more stable policy backdrop, and improving medical cost and Medicare Advantage trends as key drivers behind higher target P/E assumptions as well as modestly higher revenue growth and profit margin inputs. Analyst Commentary Recent Street research on UnitedHealth Group points to a clear shift toward more constructive views, with a series of price target increases and rating upgrades clustered around similar themes.
CNC
US$61.39
Centene
7D
-7.3%
1Y
11.8%
Narrative Update • Jun 15

CNC: Medicaid Margin Recovery And Stable Policy Backdrop Will Support Future Earnings

Centene's analyst fair value estimate has been updated from $60.51 to $80.00. This reflects a broad series of higher Street price targets as analysts highlight a more stable managed care policy backdrop, margin recovery potential, and evidence of muted medical cost trends and softer utilization across the sector.
CLOV
US$4.95
Clover Health Investments
7D
15.3%
1Y
74.7%
Narrative Update • Jun 15

CLOV: Elevated P E Expectations Will Likely Pressure Future Share Returns

Analysts have lifted their blended price target on Clover Health Investments to around $4.50, citing updated fair value estimates near $3.50, a higher discount rate of about 7.1%, revised revenue growth and profit margin assumptions, and a higher future P/E multiple. Together, these factors align with recent target moves from $2.75 to $4.75 and from $3.20 to $4.20.
ALHC
US$20.60
Alignment Healthcare
7D
7.3%
1Y
41.4%
Narrative Update • Jun 13

ALHC: Reset Multiples And Execution Risks Will Shape Balanced Return Potential

Analysts trimmed their price targets on Alignment Healthcare by $3, citing updated assumptions that include a slightly higher discount rate, a lower projected revenue growth rate, a modestly stronger profit margin, and a reduced future P/E multiple. Analyst Commentary Recent research on Alignment Healthcare sits against a broader managed care backdrop where some analysts continue to favor insurers over healthcare facilities, citing concerns about inflation and commercial mix for providers.
HQY
US$85.70
HealthEquity
7D
-4.0%
1Y
-14.3%
PGNY
US$26.60
Progyny
7D
3.0%
1Y
23.5%
MOH
US$200.21
Molina Healthcare
7D
-1.4%
1Y
-31.5%